QRISK 3® and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium Scores.

Subramanian Kannan, Murali M B Venkataraman, Salila S Chandorkar
{"title":"QRISK 3<sup>®</sup> and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium Scores.","authors":"Subramanian Kannan, Murali M B Venkataraman, Salila S Chandorkar","doi":"10.4103/ijem.ijem_27_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Diabetes mellitus is an independent risk factor for asymptomatic cardiovascular disease (CVD). The QRISK 3<sup>®</sup> score and atherosclerotic cardiovascular disease (ASCVD) risk scores determine the risk of developing CVD over 10 years. The CT coronary artery calcium score (CACS) is a non-invasive imaging modality that identifies sub-clinical atherosclerosis. We studied the correlation between the QRISK 3<sup>®</sup> and ASCVD scores and the CACS and determined the cut-off for QRISK 3<sup>®</sup> and ASCVD scores that corresponded to a moderate or accentuated CACS (≥100).</p><p><strong>Methods: </strong>In this prospective study, outpatients with diabetes and no prior coronary artery disease (CAD) or their equivalents, or having symptoms suggestive of angina or heart failure, had their QRISK 3<sup>®</sup> and ASCVD scores calculated. They subsequently underwent 256 slice cardiac CT, and CACS was calculated by the Agatston method.</p><p><strong>Results: </strong>A statistically significant correlation (r = 0.28) was found between QRISK 3<sup>®</sup> and ASCVD with CACS (<i>P</i> = 0.004 and <i>P</i> = 0.007, respectively). A QRISK<sup>®</sup> score >23 and ASCVD score >10 predicted a CACS score >100 with sensitivities of 85% and 90%, respectively.</p><p><strong>Conclusion: </strong>The QRISK 3<sup>®</sup> and ASCVD scores can be used to triage patients who require further evaluation with CACS to determine the risk of future CVD.</p>","PeriodicalId":13353,"journal":{"name":"Indian Journal of Endocrinology and Metabolism","volume":"28 6","pages":"639-644"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774411/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Endocrinology and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijem.ijem_27_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Diabetes mellitus is an independent risk factor for asymptomatic cardiovascular disease (CVD). The QRISK 3® score and atherosclerotic cardiovascular disease (ASCVD) risk scores determine the risk of developing CVD over 10 years. The CT coronary artery calcium score (CACS) is a non-invasive imaging modality that identifies sub-clinical atherosclerosis. We studied the correlation between the QRISK 3® and ASCVD scores and the CACS and determined the cut-off for QRISK 3® and ASCVD scores that corresponded to a moderate or accentuated CACS (≥100).

Methods: In this prospective study, outpatients with diabetes and no prior coronary artery disease (CAD) or their equivalents, or having symptoms suggestive of angina or heart failure, had their QRISK 3® and ASCVD scores calculated. They subsequently underwent 256 slice cardiac CT, and CACS was calculated by the Agatston method.

Results: A statistically significant correlation (r = 0.28) was found between QRISK 3® and ASCVD with CACS (P = 0.004 and P = 0.007, respectively). A QRISK® score >23 and ASCVD score >10 predicted a CACS score >100 with sensitivities of 85% and 90%, respectively.

Conclusion: The QRISK 3® and ASCVD scores can be used to triage patients who require further evaluation with CACS to determine the risk of future CVD.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.10
自引率
0.00%
发文量
75
期刊介绍: The Indian Journal of Endocrinology and Metabolism (IJEM) aims to function as the global face of Indian endocrinology research. It aims to act as a bridge between global and national advances in this field. The journal publishes thought-provoking editorials, comprehensive reviews, cutting-edge original research, focused brief communications and insightful letters to editor. The journal encourages authors to submit articles addressing aspects of science related to Endocrinology and Metabolism in particular Diabetology. Articles related to Clinical and Tropical endocrinology are especially encouraged. Sub-topic based Supplements are published regularly. This allows the journal to highlight issues relevant to Endocrine practitioners working in India as well as other countries. IJEM is free access in the true sense of the word, (it charges neither authors nor readers) and this enhances its global appeal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信